跳至主要内容
临床试验/NCT05281211
NCT05281211已完成不适用

Nutrition and EXercise Prehabilitation to Reduce Morbidity (NEXPREM) Following Major Liver Surgery in Sarcopenic Patients

San Camillo Hospital, Rome2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2022年3月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
70
试验地点
2
主要终点
Number of participants experiencing 90 day morbidity

研究概览

简要总结

NEXPREM is a single-center non-blinded randomized controlled trial investigating preoperative exercise and nutrition for sarcopenic patients in major hepatic surgery for liver malignancies. Patients with sarcopenia undergoing major hepatectomies have high rates of postoperative complications. Previous studies have demonstrated that preoperative rehabilitation with exercise and nutrition may help reduce the negative impact of sarcopenia. The investigator's hypothesis is that preoperative nutrition and exercise may reduce complications in sarcopenic patients undergoing major hepatectomies. Sarcopenic patients at diagnosis will be randomized in Group A undergoing upfront surgery and Group B undergoing preoperative rehabilitation. Outcome will be overall 90 day morbidity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Sarcopenic patients diagnosed by both qualitative and quantitative analysis.
  • •Patients with primary or secondary liver malignancies.
  • •Patients undergoing major liver resections intended as 3 or more contiguous segments
  • •Patients undergoing open, laparoscopic, or robotic resections.

排除标准

  • •Minor liver resections intended as less than 3 contiguous segments.
  • •Patients with intrahepatic, hilar, or extrahepatic cholangiocarcinomas.
  • •Patients with liver tumors for whom 6 weeks interval from diagnosis to surgery could not be waited (i.e., large HCCs on healthy livers not requiring preoperative portal vein occlusion, CRLM without preoperative administration of anti-VEGF drug who therefore do not require 6 weeks of chemotherapy washout)
  • •Patients with benign liver lesions.
  • •Patients undergoing extrahepatic liver resections.
  • •Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) procedure.
  • •Patients with physical disabilities, unable to exercise.
  • •Patients with inadequate kidney function.

研究组 & 干预措施

Preoperative Nutrition+Exercise

Experimental

Preoperative nutrition and exercise pre-habilitation followed by major liver resection.

干预措施: Nutrition (Dietary Supplement)

Preoperative Nutrition+Exercise

Experimental

Preoperative nutrition and exercise pre-habilitation followed by major liver resection.

干预措施: Exercise (Behavioral)

Upfront Surgery

No Intervention

Upfront major liver resection.

结局指标

主要结局

Number of participants experiencing 90 day morbidity

时间窗: 90 days

Patients experiencing complications within 90 days of surgery

次要结局

  • Number of participants being readmitted within 90 days of surgery.(90 days)
  • Number of participants being disease free (Disease free survival)(3 years)
  • Number of participants experiencing 90 days postoperative major complications according to Clavien-Dindo classification(90 days)
  • Number of participants experiencing 90 days postoperative mortality.(90 days)
  • Number of participants being Sarcopenic after 6 weeks of prehabilitation.(6 weeks)
  • Number of participants Alive ( Overall Survival)(3 years)

研究者

发起方
San Camillo Hospital, Rome
申办方类型
Other
责任方
Principal Investigator
主要研究者

Giammauro Berardi

Principal Investigator

San Camillo Hospital, Rome

研究点 (2)

Loading locations...

相似试验

Nutrition and Exercise Prehabilitation to Reduce... | 临床试验